13 November 2019

Making Medicines, from Laboratory to Pilot Plant Manufacture

Organised by:

SCI's London Group & MSD

MSD, London, UK

Register on Eventbrite

Registration Closed

This event is no longer available for registration.

Synopsis

The journey of a successful medicine from discovery through development, to the treatment of patients is a long and complex process. One crucial aspect of this is the manufacture of the active pharmaceutical ingredient (API), with ever increasing quantities required from initially grams for safety testing, up to potentially thousands of kilograms for a commercial marketed medicine.

This talk will provide a general overview of the development process. More detailed stories from the laboratory synthesis of potential medicines currently in the early stages of development, up to the large-scale manufacture of more advanced projects in a specialised Pilot Plant will also be shared. Focus and comparison on the changing technical, safety, accommodation and regulatory challenges during this journey will offer an engaging insight for all those interested in how medicines are made.

Speakers:
Dr James Douglas, AstraZeneca UK
Abi Thorne, AstraZeneca UK

Time: 18:00 for 18:30


Venue and Contact

Merck Sharp & Dohme

2 Pancras Square
London
N1C 4AG

Email: communications@soci.org


Fees

This is a free event but please register to book your place.

Become an SCI Member and save on this and future events

See Membership Options

Sign up as an Event Member to join this event. SCI Full or Student Members receive discounts on event registrations


Booking Process

Read our event booking terms and conditions


Partners